MPS Limited (BOM:532440)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	39,059	48,316	26,046	18,165	10,092	8,355
Market Cap Growth	36.00%	85.50%	43.39%	80.00%	20.78%	114.48%
Enterprise Value	38,038	47,388	24,433	17,126	8,724	6,967
Last Close Price	2307.10	2848.60	1478.98	994.29	525.87	416.05
PE Ratio	24.68	32.45	21.93	16.64	11.58	14.27
PS Ratio	5.33	6.65	4.78	3.63	2.25	1.98
PB Ratio	8.16	10.10	5.66	4.25	2.75	2.19
P/TBV Ratio	24.54	30.36	27.07	6.64	3.96	3.19
P/FCF Ratio	-	51.04	22.78	16.74	9.12	8.94
P/OCF Ratio	-	47.89	22.07	16.10	8.79	8.41
EV/Sales Ratio	5.19	6.52	4.48	3.42	1.94	1.65
EV/EBITDA Ratio	17.02	22.47	14.93	11.37	7.49	7.19
EV/EBIT Ratio	19.75	25.83	16.27	12.37	8.26	8.03
EV/FCF Ratio	-	50.06	21.37	15.78	7.88	7.45
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.03	0.05
Debt / EBITDA Ratio	0.02	0.02	0.03	0.05	0.10	0.18
Debt / FCF Ratio	-	0.04	0.04	0.07	0.11	0.20
Asset Turnover	-	1.02	0.84	0.95	0.89	0.89
Quick Ratio	-	1.41	1.50	3.22	2.57	2.51
Current Ratio	-	1.97	1.61	3.36	2.71	2.66
Return on Equity (ROE)	-	31.74%	26.78%	27.50%	23.29%	15.66%
Return on Assets (ROA)	-	16.02%	14.47%	16.36%	13.14%	11.41%
Return on Capital (ROIC)	25.43%	24.23%	20.87%	21.27%	16.95%	13.82%
Return on Capital Employed (ROCE)	-	34.20%	28.40%	30.50%	27.20%	21.40%
Earnings Yield	4.05%	3.08%	4.56%	6.01%	8.63%	7.01%
FCF Yield	-	1.96%	4.39%	5.97%	10.97%	11.19%
Dividend Yield	3.49%	2.91%	5.07%	2.01%	5.71%	-
Payout Ratio	-	90.30%	72.20%	47.00%	-	-
Buyback Yield / Dilution	-0.03%	0.01%	0.70%	4.62%	2.29%	1.47%
Total Shareholder Return	3.47%	2.93%	5.77%	6.63%	8.00%	1.47%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.